Market Outlook
The global Total Artificial Heart market size was valued at USD 40 million in 2022 and is forecast to a readjusted size of USD 150.3 million by 2029 with a CAGR of 20.8% during review period.
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
This report is a detailed and comprehensive analysis for global Total Artificial Heart market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Total Artificial Heart market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2018-2029
Global Total Artificial Heart market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2018-2029
Global Total Artificial Heart market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2018-2029
Global Total Artificial Heart market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Total Artificial Heart
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Total Artificial Heart market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Segmentation By Type
SynCardia
Others
Segmentation By Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the key strengths of the Total Artificial Heart market in 2025?
The Total Artificial Heart (TAH) market in 2025 will benefit from advanced technological innovations, increased investment in healthcare R&D, and an expanding patient pool requiring heart transplants. These strengths will drive market growth, especially with improved heart designs and enhanced durability, offering patients longer lifespans and better quality of life. Additionally, there will be growing acceptance and use in emergency heart failure cases where donor hearts are not available.
What weaknesses might affect the Total Artificial Heart market?
The high cost of production and the complexity of implantation procedures may limit accessibility for a wider patient population, especially in lower-income regions. The technology is still evolving, and complications related to device performance, such as clotting, infections, and mechanical failures, could undermine long-term patient outcomes. Additionally, there are limited healthcare facilities capable of providing this level of specialized treatment, creating a barrier to market expansion.
What opportunities exist in the Total Artificial Heart market?
The increasing prevalence of heart failure, especially in aging populations, presents a significant growth opportunity. Advances in material science and miniaturization of components offer the potential for more efficient, less invasive solutions. There is also a growing interest from governments and healthcare organizations in improving heart transplant accessibility, which could result in supportive policies, subsidies, and a more extensive global market. Further, collaborations with biotech and healthcare companies could lead to improved versions of the TAH.
What threats could challenge the Total Artificial Heart market?
One of the primary threats is the risk of competing technologies, such as ventricular assist devices (VADs) or regenerative medicine, becoming more effective and widely adopted. Regulatory hurdles and the lengthy approval process for new devices could also delay market penetration. Moreover, ethical concerns around artificial organs and potential complications in long-term usage might slow down patient and healthcare provider acceptance. Lastly, the shortage of skilled surgeons and healthcare professionals capable of performing these intricate procedures may limit widespread adoption.
Market PESTEL Analysis
How will political factors influence the Total Artificial Heart market in 2025?
Political factors, particularly healthcare policies and government regulations will play a crucial role in shaping the Total Artificial Heart (TAH) market. Governments may push for more funding for research and development in advanced medical devices, and offer subsidies or tax incentives for manufacturers. However, any changes in health insurance policies or reimbursement structures could impact market growth, as TAH procedures are expensive and may not always be covered.
What economic factors will impact the Total Artificial Heart market?
The Total Artificial Heart market’s growth will depend on the economic conditions in different regions. In developed countries with robust healthcare systems, economic stability and higher healthcare spending will allow for more investment in these advanced technologies. However, economic downturns or financial constraints in emerging markets could limit the affordability and adoption of TAHs. Moreover, high manufacturing and operational costs may slow down widespread commercial adoption, limiting its reach to wealthier segments of society.
How will social factors affect the Total Artificial Heart market?
The social acceptance of Total Artificial Hearts will be a key factor. As heart disease rates continue to rise globally, there will be increased demand for alternative solutions like TAHs. However, social stigma surrounding artificial organs and patient hesitancy due to perceived risks or ethical concerns could slow adoption. Public awareness campaigns and education about the benefits and risks of TAHs will be essential in mitigating these social barriers and improving patient confidence.
What technological advancements will influence the Total Artificial Heart market?
Technological innovation will be a significant driver for the Total Artificial Heart market. Advances in biomaterials, miniaturization, and artificial intelligence could lead to more efficient and reliable devices, improving patient outcomes and longevity. Developments in wireless monitoring systems and autonomous adjustments to the heart’s functioning will make TAHs more user-friendly and less invasive, encouraging wider adoption. Ongoing research into biocompatibility and integration with the human body will be critical for improving device performance.
What environmental factors will affect the Total Artificial Heart market?
Environmental concerns will be a minor factor in the Total Artificial Heart market. However, the environmental impact of manufacturing, disposal, and recycling of medical devices will become more important as sustainability practices gain traction across industries. Manufacturers will need to consider eco-friendly production processes and materials to minimize their carbon footprint. Moreover, as the healthcare sector moves toward sustainability, there may be stricter regulations on the disposal of medical waste and devices.
How will legal factors impact the Total Artificial Heart market?
Legal factors such as product safety standards, intellectual property rights, and liability laws will have a significant impact on the market. Strict regulations on the safety and efficacy of medical devices could delay approval processes but ensure that only the highest-quality products reach the market. Additionally, intellectual property protections will incentivize manufacturers to invest in research and innovation, but any potential legal challenges related to device malfunctions or long-term effects could hurt market growth.
Market SIPOC Analysis
Who are the suppliers in the Total Artificial Heart market in 2025?
The suppliers in the Total Artificial Heart (TAH) market will primarily include manufacturers of high-tech medical devices, including heart pumps, electronic systems, and biomaterials. Key suppliers will also include companies that provide advanced materials like biocompatible polymers and titanium for device construction. Additionally, suppliers of manufacturing equipment, sensors, and software for device monitoring and management will be crucial players.
What inputs are necessary for the Total Artificial Heart market?
The inputs required for the Total Artificial Heart market include advanced medical technologies, specialized raw materials (e.g., metals, polymers, and bio-compatible coatings), and highly skilled personnel for research and development. Investment in clinical trials, regulatory approvals, and partnerships with healthcare institutions are also essential inputs. Furthermore, data from patients' health outcomes and technological feedback loops will help refine and improve future models.
What are the processes involved in the Total Artificial Heart market?
The process involves several stages, starting with research and development of the heart's design, including material testing and clinical trials. Once the design is optimized, manufacturers move into the production stage, where components like pumps, sensors, and power units are assembled. After manufacturing, the heart devices undergo rigorous testing for safety and durability before being approved for use. Lastly, post-market monitoring and support, including regular check-ups and device adjustments, form the final part of the process.
Who are the customers of the Total Artificial Heart market?
The primary customers are hospitals and healthcare institutions that specialize in treating patients with severe heart failure. These institutions may purchase TAH devices either directly or through medical equipment distributors. Patients who require heart transplants and are unable to find suitable donors will be the end-users. Additionally, healthcare providers like cardiologists and surgical teams play an important role in determining the suitability of a TAH for specific patients.
What are the expected outcomes from the Total Artificial Heart market in 2025?
The expected outcomes include the successful implantation of more Total Artificial Heart devices, leading to improved survival rates and quality of life for patients with end-stage heart failure. The market will also see the advancement of TAH technology, including more efficient, durable, and smaller devices. There may also be better integration with healthcare systems, ensuring that monitoring, diagnostics, and patient care are more streamlined. Furthermore, improved patient outcomes and fewer complications will strengthen the adoption of TAHs in heart failure management.
Market Porter's Five Forces
How intense is the competitive rivalry in the Total Artificial Heart market in 2025?
The competitive rivalry in the Total Artificial Heart (TAH) market will be moderate to high. While there are only a few leading companies focusing on this niche, the technological complexity and cost of developing TAH devices mean that companies with large resources will be the primary players. As innovation drives the market forward, companies will compete fiercely to improve device performance, reduce costs, and enhance patient outcomes. However, the market is still in an emerging phase, so competition is expected to grow in the coming years.
What is the threat of new entrants in the Total Artificial Heart market?
The threat of new entrants in the Total Artificial Heart market is relatively low. The high cost of research and development, along with stringent regulatory hurdles and the need for highly specialized knowledge and infrastructure, creates significant barriers to entry. Established players with a strong presence in the medical device industry will dominate this market due to the expertise and resources required for developing TAHs. New entrants will need to invest heavily in innovation, clinical trials, and manufacturing capabilities to compete effectively.
How strong is the bargaining power of suppliers in the Total Artificial Heart market?
The bargaining power of suppliers in the Total Artificial Heart market is moderate to high. The production of Total Artificial Hearts relies on highly specialized materials, such as biocompatible metals and polymers, and advanced technologies for sensors and power systems. There are relatively few suppliers who provide these critical components, which gives them significant leverage. However, as the market grows and more suppliers enter, the bargaining power may decrease slightly.
How strong is the bargaining power of buyers in the Total Artificial Heart market?
The bargaining power of buyers in the Total Artificial Heart market is low to moderate. Buyers, in this case, are primarily hospitals, healthcare providers, and patients. While hospitals and healthcare providers may have some negotiating power due to the volume of devices they purchase, the high specialization and cost of TAHs reduce their ability to negotiate significantly. For patients, the power is limited because their options for heart failure treatment are few, especially when considering the lack of viable donor organs.
What is the threat of substitute products or services in the Total Artificial Heart market?
The threat of substitutes in the Total Artificial Heart market is moderate. While alternatives like ventricular assist devices (VADs) are available for heart failure patients, they do not completely replace the function of a failing heart like TAHs can. Other alternatives, such as stem cell therapy or gene editing, are still in early stages of development and are not yet ready for widespread clinical use. Therefore, while substitutes may evolve, they are not expected to pose a significant threat in the immediate future.
Market Upstream Analysis
What are the key raw materials and components needed for the Total Artificial Heart market?
The key raw materials and components needed for the Total Artificial Heart market include biocompatible metals like titanium and stainless steel, advanced polymers for blood flow interfaces, high-performance pumps, sensors for monitoring, and power supply systems. Additionally, components for wireless communication and software for device management are crucial. The quality and innovation in these materials directly impact the performance, safety, and longevity of the TAH devices.
Who are the main suppliers involved in the upstream part of the Total Artificial Heart market?
The main suppliers involved in the upstream part of the Total Artificial Heart market include companies specializing in the development of high-quality medical-grade materials (e.g., biomaterials suppliers), manufacturers of microelectronics and sensors, and suppliers of specialized manufacturing equipment. Additionally, firms providing advanced manufacturing technologies like 3D printing for precise component fabrication also play an important role. Research institutions collaborating on clinical trials and innovations are also key upstream partners.
How does technology development impact the upstream sector of the Total Artificial Heart market?
Technological advancements significantly affect the upstream sector by driving demand for more innovative materials and components. The continuous improvement of biocompatible materials, such as more durable polymers or advanced alloys, will be essential for creating more effective, long-lasting Total Artificial Hearts. Additionally, advancements in sensor technology, power management systems, and miniaturization of components will shape how suppliers adapt and innovate in response to the market’s evolving needs.
What regulatory requirements impact the upstream sector of the Total Artificial Heart market?
Regulatory requirements such as FDA approval in the U.S. or CE marking in Europe place strict guidelines on the materials, manufacturing processes, and safety testing procedures for Total Artificial Hearts. Suppliers must adhere to these standards to ensure that the raw materials and components used in TAH production are safe, effective, and compliant with medical device regulations. These regulations also impact the supply chain as manufacturers must work with certified suppliers and maintain quality assurance protocols.
What are the key challenges faced by suppliers in the upstream sector of the Total Artificial Heart market?
Suppliers in the upstream sector face challenges related to the high cost of research and development, maintaining product quality standards, and meeting the specialized demands of TAH production. The need for continuous innovation to keep up with advancements in biomaterials and miniaturization of components is another challenge. Additionally, the long and complex regulatory approval process for medical devices can create delays and uncertainties for suppliers, affecting their ability to respond quickly to market demands.
Market Midstream Analysis
What are the key activities involved in the midstream sector of the Total Artificial Heart market?
The key activities in the midstream sector of the Total Artificial Heart market include the assembly, testing, and manufacturing of the Total Artificial Heart devices. This involves integrating components like pumps, sensors, and power units into a functioning system, followed by rigorous quality control and safety testing. Clinical trials and the acquisition of regulatory approvals also take place in the midstream phase to ensure that the devices meet necessary standards for performance and patient safety.
Who are the key players in the midstream sector of the Total Artificial Heart market?
The key players in the midstream sector include specialized medical device manufacturers and large healthcare companies that focus on high-tech heart implants. Companies that handle the assembly, final testing, and packaging of Total Artificial Heart devices are crucial. Additionally, contract manufacturers and partners handling clinical trial management and device validation play an essential role in bringing the products to market.
How do distribution and logistics affect the midstream sector of the Total Artificial Heart market?
Distribution and logistics are vital in the midstream sector because Total Artificial Hearts are highly specialized medical devices that require precise handling, storage, and transportation. Timely delivery to hospitals and surgical centers is critical, as is ensuring that the devices are stored in optimal conditions before use. Efficient logistics networks, along with collaboration with healthcare providers for inventory management, will be key to ensuring that TAHs are available when needed for implantation.
What challenges do companies face in the midstream sector of the Total Artificial Heart market?
Companies in the midstream sector face challenges related to maintaining the consistency and quality of the manufacturing process, given the complexity of Total Artificial Hearts. The need to meet stringent regulatory requirements and timelines for clinical trials can delay product availability. Additionally, managing the supply chain for such highly specialized components, and the costs associated with maintaining stringent standards, can create operational challenges. The risk of device failure or post-market complications may also increase the complexity of midstream operations.
How will innovation in production technologies affect the midstream sector of the Total Artificial Heart market?
Innovation in production technologies, such as automation, advanced robotics, and 3D printing, will improve the efficiency and precision of manufacturing processes in the midstream sector. These technologies will help reduce production costs, shorten lead times, and improve the overall quality and customization of Total Artificial Heart devices. Continuous innovation in materials handling and assembly techniques will allow companies to meet the growing demand for more efficient and smaller devices, improving patient outcomes while making production more scalable.
Market Downstream Analysis
What are the key activities involved in the downstream sector of the Total Artificial Heart market?
The key activities in the downstream sector of the Total Artificial Heart market include the implantation of the devices in patients, ongoing patient monitoring, and post-operative care. Healthcare providers, such as hospitals and cardiology centers, play a central role in this stage. After the devices are implanted, they require continuous monitoring for performance, complications, and potential adjustments. Additionally, education and training for patients and healthcare providers are essential for ensuring optimal use of the device.
Who are the key players in the downstream sector of the Total Artificial Heart market?
The key players in the downstream sector include hospitals, heart failure clinics, cardiologists, cardiac surgeons, and healthcare professionals specializing in the management of end-stage heart failure. Medical device distributors also play a role in ensuring that the Total Artificial Heart devices reach healthcare providers. Patient advocacy groups may also be involved, helping to raise awareness about the availability of these devices and supporting patient access.
How does the marketing and sales process affect the downstream sector of the Total Artificial Heart market?
The marketing and sales process in the downstream sector is largely driven by direct sales to hospitals, healthcare providers, and surgical centers. Manufacturers work closely with medical professionals to demonstrate the benefits and outcomes of Total Artificial Hearts. Education and training programs are essential to ensure that healthcare teams can effectively use the devices. Additionally, insurance companies and reimbursement policies play a significant role in making the devices accessible to patients, which impacts sales and adoption rates.
What challenges are faced by companies in the downstream sector of the Total Artificial Heart market?
Companies in the downstream sector face challenges related to the high cost of Total Artificial Heart devices, which can limit patient access, especially in regions with lower healthcare funding. The complexity of implantation surgeries requires highly trained surgical teams, and not all hospitals have the required infrastructure. Furthermore, post-operative care and long-term monitoring present challenges, as patients may need continuous follow-up to detect potential complications. Insurance coverage and reimbursement for these expensive devices can also vary significantly, influencing patient access and adoption.
How will advancements in patient care and follow-up impact the downstream sector of the Total Artificial Heart market?
Advancements in patient care, such as improved monitoring technologies, telemedicine, and personalized care plans, will enhance the downstream sector by improving patient outcomes and reducing complications. Remote monitoring of device performance can allow for early detection of issues, potentially reducing hospital readmissions. Additionally, innovations in rehabilitation and post-implantation care will help patients recover faster and adjust to their new devices, improving overall satisfaction and success rates, which could increase the adoption of Total Artificial Hearts.
Chapter 1, to describe Total Artificial Heart product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Total Artificial Heart, with price, sales, revenue and global market share of Total Artificial Heart from 2018 to 2023.
Chapter 3, the Total Artificial Heart competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Total Artificial Heart breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Total Artificial Heart market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Total Artificial Heart.
Chapter 14 and 15, to describe Total Artificial Heart sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Total Artificial Heart
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Total Artificial Heart Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 SynCardia
1.3.3 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Total Artificial Heart Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Dilated Cardiomyopathy
1.4.3 Ischemic Cardiomyopathy
1.4.4 Others
1.5 Global Total Artificial Heart Market Size & Forecast
1.5.1 Global Total Artificial Heart Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Total Artificial Heart Sales Quantity (2018-2029)
1.5.3 Global Total Artificial Heart Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BiVACOR
2.1.1 BiVACOR Details
2.1.2 BiVACOR Major Business
2.1.3 BiVACOR Total Artificial Heart Product and Services
2.1.4 BiVACOR Total Artificial Heart Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BiVACOR Recent Developments/Updates
2.2 SynCardia
2.2.1 SynCardia Details
2.2.2 SynCardia Major Business
2.2.3 SynCardia Total Artificial Heart Product and Services
2.2.4 SynCardia Total Artificial Heart Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 SynCardia Recent Developments/Updates
2.3 Jarvik Heart
2.3.1 Jarvik Heart Details
2.3.2 Jarvik Heart Major Business
2.3.3 Jarvik Heart Total Artificial Heart Product and Services
2.3.4 Jarvik Heart Total Artificial Heart Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Jarvik Heart Recent Developments/Updates
2.4 CARMAT
2.4.1 CARMAT Details
2.4.2 CARMAT Major Business
2.4.3 CARMAT Total Artificial Heart Product and Services
2.4.4 CARMAT Total Artificial Heart Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CARMAT Recent Developments/Updates
2.5 AbioMed
2.5.1 AbioMed Details
2.5.2 AbioMed Major Business
2.5.3 AbioMed Total Artificial Heart Product and Services
2.5.4 AbioMed Total Artificial Heart Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AbioMed Recent Developments/Updates
3 Competitive Environment: Total Artificial Heart by Manufacturer
3.1 Global Total Artificial Heart Sales Quantity by Manufacturer (2018-2023)
3.2 Global Total Artificial Heart Revenue by Manufacturer (2018-2023)
3.3 Global Total Artificial Heart Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Total Artificial Heart by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Total Artificial Heart Manufacturer Market Share in 2022
3.4.2 Top 6 Total Artificial Heart Manufacturer Market Share in 2022
3.5 Total Artificial Heart Market: Overall Company Footprint Analysis
3.5.1 Total Artificial Heart Market: Region Footprint
3.5.2 Total Artificial Heart Market: Company Product Type Footprint
3.5.3 Total Artificial Heart Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Total Artificial Heart Market Size by Region
4.1.1 Global Total Artificial Heart Sales Quantity by Region (2018-2029)
4.1.2 Global Total Artificial Heart Consumption Value by Region (2018-2029)
4.1.3 Global Total Artificial Heart Average Price by Region (2018-2029)
4.2 North America Total Artificial Heart Consumption Value (2018-2029)
4.3 Europe Total Artificial Heart Consumption Value (2018-2029)
4.4 Asia-Pacific Total Artificial Heart Consumption Value (2018-2029)
4.5 South America Total Artificial Heart Consumption Value (2018-2029)
4.6 Middle East and Africa Total Artificial Heart Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Total Artificial Heart Sales Quantity by Type (2018-2029)
5.2 Global Total Artificial Heart Consumption Value by Type (2018-2029)
5.3 Global Total Artificial Heart Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Total Artificial Heart Sales Quantity by Application (2018-2029)
6.2 Global Total Artificial Heart Consumption Value by Application (2018-2029)
6.3 Global Total Artificial Heart Average Price by Application (2018-2029)
7 North America
7.1 North America Total Artificial Heart Sales Quantity by Type (2018-2029)
7.2 North America Total Artificial Heart Sales Quantity by Application (2018-2029)
7.3 North America Total Artificial Heart Market Size by Country
7.3.1 North America Total Artificial Heart Sales Quantity by Country (2018-2029)
7.3.2 North America Total Artificial Heart Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Total Artificial Heart Sales Quantity by Type (2018-2029)
8.2 Europe Total Artificial Heart Sales Quantity by Application (2018-2029)
8.3 Europe Total Artificial Heart Market Size by Country
8.3.1 Europe Total Artificial Heart Sales Quantity by Country (2018-2029)
8.3.2 Europe Total Artificial Heart Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Total Artificial Heart Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Total Artificial Heart Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Total Artificial Heart Market Size by Region
9.3.1 Asia-Pacific Total Artificial Heart Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Total Artificial Heart Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Total Artificial Heart Sales Quantity by Type (2018-2029)
10.2 South America Total Artificial Heart Sales Quantity by Application (2018-2029)
10.3 South America Total Artificial Heart Market Size by Country
10.3.1 South America Total Artificial Heart Sales Quantity by Country (2018-2029)
10.3.2 South America Total Artificial Heart Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Total Artificial Heart Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Total Artificial Heart Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Total Artificial Heart Market Size by Country
11.3.1 Middle East & Africa Total Artificial Heart Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Total Artificial Heart Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Total Artificial Heart Market Drivers
12.2 Total Artificial Heart Market Restraints
12.3 Total Artificial Heart Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Total Artificial Heart and Key Manufacturers
13.2 Manufacturing Costs Percentage of Total Artificial Heart
13.3 Total Artificial Heart Production Process
13.4 Total Artificial Heart Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Total Artificial Heart Typical Distributors
14.3 Total Artificial Heart Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Total Artificial Heart Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Total Artificial Heart Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BiVACOR Basic Information, Manufacturing Base and Competitors
Table 4. BiVACOR Major Business
Table 5. BiVACOR Total Artificial Heart Product and Services
Table 6. BiVACOR Total Artificial Heart Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BiVACOR Recent Developments/Updates
Table 8. SynCardia Basic Information, Manufacturing Base and Competitors
Table 9. SynCardia Major Business
Table 10. SynCardia Total Artificial Heart Product and Services
Table 11. SynCardia Total Artificial Heart Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. SynCardia Recent Developments/Updates
Table 13. Jarvik Heart Basic Information, Manufacturing Base and Competitors
Table 14. Jarvik Heart Major Business
Table 15. Jarvik Heart Total Artificial Heart Product and Services
Table 16. Jarvik Heart Total Artificial Heart Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Jarvik Heart Recent Developments/Updates
Table 18. CARMAT Basic Information, Manufacturing Base and Competitors
Table 19. CARMAT Major Business
Table 20. CARMAT Total Artificial Heart Product and Services
Table 21. CARMAT Total Artificial Heart Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. CARMAT Recent Developments/Updates
Table 23. AbioMed Basic Information, Manufacturing Base and Competitors
Table 24. AbioMed Major Business
Table 25. AbioMed Total Artificial Heart Product and Services
Table 26. AbioMed Total Artificial Heart Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AbioMed Recent Developments/Updates
Table 28. Global Total Artificial Heart Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 29. Global Total Artificial Heart Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Total Artificial Heart Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 31. Market Position of Manufacturers in Total Artificial Heart, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Total Artificial Heart Production Site of Key Manufacturer
Table 33. Total Artificial Heart Market: Company Product Type Footprint
Table 34. Total Artificial Heart Market: Company Product Application Footprint
Table 35. Total Artificial Heart New Market Entrants and Barriers to Market Entry
Table 36. Total Artificial Heart Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Total Artificial Heart Sales Quantity by Region (2018-2023) & (Units)
Table 38. Global Total Artificial Heart Sales Quantity by Region (2024-2029) & (Units)
Table 39. Global Total Artificial Heart Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Total Artificial Heart Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Total Artificial Heart Average Price by Region (2018-2023) & (USD/Unit)
Table 42. Global Total Artificial Heart Average Price by Region (2024-2029) & (USD/Unit)
Table 43. Global Total Artificial Heart Sales Quantity by Type (2018-2023) & (Units)
Table 44. Global Total Artificial Heart Sales Quantity by Type (2024-2029) & (Units)
Table 45. Global Total Artificial Heart Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Total Artificial Heart Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Total Artificial Heart Average Price by Type (2018-2023) & (USD/Unit)
Table 48. Global Total Artificial Heart Average Price by Type (2024-2029) & (USD/Unit)
Table 49. Global Total Artificial Heart Sales Quantity by Application (2018-2023) & (Units)
Table 50. Global Total Artificial Heart Sales Quantity by Application (2024-2029) & (Units)
Table 51. Global Total Artificial Heart Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Total Artificial Heart Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Total Artificial Heart Average Price by Application (2018-2023) & (USD/Unit)
Table 54. Global Total Artificial Heart Average Price by Application (2024-2029) & (USD/Unit)
Table 55. North America Total Artificial Heart Sales Quantity by Type (2018-2023) & (Units)
Table 56. North America Total Artificial Heart Sales Quantity by Type (2024-2029) & (Units)
Table 57. North America Total Artificial Heart Sales Quantity by Application (2018-2023) & (Units)
Table 58. North America Total Artificial Heart Sales Quantity by Application (2024-2029) & (Units)
Table 59. North America Total Artificial Heart Sales Quantity by Country (2018-2023) & (Units)
Table 60. North America Total Artificial Heart Sales Quantity by Country (2024-2029) & (Units)
Table 61. North America Total Artificial Heart Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Total Artificial Heart Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Total Artificial Heart Sales Quantity by Type (2018-2023) & (Units)
Table 64. Europe Total Artificial Heart Sales Quantity by Type (2024-2029) & (Units)
Table 65. Europe Total Artificial Heart Sales Quantity by Application (2018-2023) & (Units)
Table 66. Europe Total Artificial Heart Sales Quantity by Application (2024-2029) & (Units)
Table 67. Europe Total Artificial Heart Sales Quantity by Country (2018-2023) & (Units)
Table 68. Europe Total Artificial Heart Sales Quantity by Country (2024-2029) & (Units)
Table 69. Europe Total Artificial Heart Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Total Artificial Heart Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Total Artificial Heart Sales Quantity by Type (2018-2023) & (Units)
Table 72. Asia-Pacific Total Artificial Heart Sales Quantity by Type (2024-2029) & (Units)
Table 73. Asia-Pacific Total Artificial Heart Sales Quantity by Application (2018-2023) & (Units)
Table 74. Asia-Pacific Total Artificial Heart Sales Quantity by Application (2024-2029) & (Units)
Table 75. Asia-Pacific Total Artificial Heart Sales Quantity by Region (2018-2023) & (Units)
Table 76. Asia-Pacific Total Artificial Heart Sales Quantity by Region (2024-2029) & (Units)
Table 77. Asia-Pacific Total Artificial Heart Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Total Artificial Heart Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Total Artificial Heart Sales Quantity by Type (2018-2023) & (Units)
Table 80. South America Total Artificial Heart Sales Quantity by Type (2024-2029) & (Units)
Table 81. South America Total Artificial Heart Sales Quantity by Application (2018-2023) & (Units)
Table 82. South America Total Artificial Heart Sales Quantity by Application (2024-2029) & (Units)
Table 83. South America Total Artificial Heart Sales Quantity by Country (2018-2023) & (Units)
Table 84. South America Total Artificial Heart Sales Quantity by Country (2024-2029) & (Units)
Table 85. South America Total Artificial Heart Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Total Artificial Heart Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Total Artificial Heart Sales Quantity by Type (2018-2023) & (Units)
Table 88. Middle East & Africa Total Artificial Heart Sales Quantity by Type (2024-2029) & (Units)
Table 89. Middle East & Africa Total Artificial Heart Sales Quantity by Application (2018-2023) & (Units)
Table 90. Middle East & Africa Total Artificial Heart Sales Quantity by Application (2024-2029) & (Units)
Table 91. Middle East & Africa Total Artificial Heart Sales Quantity by Region (2018-2023) & (Units)
Table 92. Middle East & Africa Total Artificial Heart Sales Quantity by Region (2024-2029) & (Units)
Table 93. Middle East & Africa Total Artificial Heart Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Total Artificial Heart Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Total Artificial Heart Raw Material
Table 96. Key Manufacturers of Total Artificial Heart Raw Materials
Table 97. Total Artificial Heart Typical Distributors
Table 98. Total Artificial Heart Typical Customers
List of Figures
Figure 1. Total Artificial Heart Picture
Figure 2. Global Total Artificial Heart Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Total Artificial Heart Consumption Value Market Share by Type in 2022
Figure 4. SynCardia Examples
Figure 5. Others Examples
Figure 6. Global Total Artificial Heart Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Total Artificial Heart Consumption Value Market Share by Application in 2022
Figure 8. Dilated Cardiomyopathy Examples
Figure 9. Ischemic Cardiomyopathy Examples
Figure 10. Others Examples
Figure 11. Global Total Artificial Heart Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Total Artificial Heart Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Total Artificial Heart Sales Quantity (2018-2029) & (Units)
Figure 14. Global Total Artificial Heart Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Total Artificial Heart Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Total Artificial Heart Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Total Artificial Heart by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Total Artificial Heart Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Total Artificial Heart Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Total Artificial Heart Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Total Artificial Heart Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Total Artificial Heart Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Total Artificial Heart Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Total Artificial Heart Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Total Artificial Heart Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Total Artificial Heart Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Total Artificial Heart Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Total Artificial Heart Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Total Artificial Heart Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Total Artificial Heart Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Total Artificial Heart Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Total Artificial Heart Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Total Artificial Heart Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Total Artificial Heart Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Total Artificial Heart Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Total Artificial Heart Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Total Artificial Heart Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Total Artificial Heart Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Total Artificial Heart Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Total Artificial Heart Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Total Artificial Heart Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Total Artificial Heart Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Total Artificial Heart Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Total Artificial Heart Consumption Value Market Share by Region (2018-2029)
Figure 53. China Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Total Artificial Heart Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Total Artificial Heart Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Total Artificial Heart Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Total Artificial Heart Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Total Artificial Heart Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Total Artificial Heart Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Total Artificial Heart Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Total Artificial Heart Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Total Artificial Heart Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Total Artificial Heart Market Drivers
Figure 74. Total Artificial Heart Market Restraints
Figure 75. Total Artificial Heart Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Total Artificial Heart in 2022
Figure 78. Manufacturing Process Analysis of Total Artificial Heart
Figure 79. Total Artificial Heart Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
